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Summary Multiple pilomatricomas are rare. In the literature, they 
have been associated with many conditions, although the most 
common association is with myotonic dystrophy. We present a new 
association not previously described in the literature, observed 
in a 28-year-old male with three pilomatricomas, who had been 
diagnosed with seminoma 15 months before the current diagnosis 
of multiple pilomatricomas. Concerning the current association, as 
well as many of those described in the literature, we also discuss 
whether they might be more than mere coincidences, maybe 
explained by some molecular alterations.
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CaSe report
 We present a 28-year-old male patient who 
came to the hospital with a complaint of several 
subcutaneous nodules. Fifteen months before, the 
patient had been diagnosed with classic semino-
ma of 1.5 cm in size, pT1, N0, M0, S0, of the left 
testis (Fig. 1). Radical left orchydectomy was then 
performed. No signs or symptoms of recurrence 
were present.
 Current exploration revealed three subcutane-
ous, hard nodules, distributed in the right forearm, 
left arm and left buttock. The biggest of the nod-
ules measured 1.3 cm. The three lesions were re-
moved and morphological study showed them to 
correspond to typical pilomatricomas, with classic 
shadow cells (Fig. 2). All of them presented focal 
calcification, and two of them (left arm and but-
tock) also presented focal ossification.
diSCuSSion
 Multiple pilomatricomas (MP) are a rare event 
(1-4), accounting for 2% to 3.5% of the reported 
cases of pilomatricoma (4). The concept of MP 
includes either simultaneous presentation or pre-
sentation of different tumors in the same patient 
at some time intervals (4). Up to 31 lesions in the 
same patient have been reported (5). Some histo-
logic variants such as the perforant (6) or giant (7) 
variants have also been described in the form of 
MP (8). Ossification in pilomatricoma is not such a 
rare event since it can be observed in up to 15% 
to 20% of cases (9). 
 MP have been associated to myotonic dystro-
phy (5,10-13), Churg-Strauss and Rubinstein-Tay-
bi syndrome (14,15), spina bifida (16), sternal cleft 
and mild coagulative defect (17), trisomy 9 (18), or 
celiac disease (1). 
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 The question is whether so much attention in 
the literature is due to any specific association be-
tween PM and any of these diseases, or it is, on 
the contrary, just the result of mere coincidences.
Although the reason why some patients develop 
MP is unknown, some argue that mutations in 
beta-catenin may explain at least some cases (3). 
Earlier, some authors found that pilomatricoma 
(not necessarily MP) was associated with altera-
tions in the beta-catenin gene (19,20). Different 
mutations have been described. The most con-
stant one seems to be that of the CTNNB1 gene, 
which appears in up to 100% of cases in some 
series (20). A heterozygote missense mutation at 
codon 32 (D32Y) has been a common finding to 
a lower percentage of pilomatricomas in some se-
ries (20,21).
 One of the targets of the beta-catenin pathway 
is the gene that encodes c-MYC, which ultimately 
relates the whole pathway to adenomatous polyp-
osis coli. Curiously, multiple pilomatricomas have 
been occasionally associated to Gardner syn-
drome (22). Other coincidences between MP and 
other diseases that have been described in the lit-
erature could also perhaps be related in the future 
to beta-catenin alterations. For instance, beta-
catenin has been demonstrated to be reduced in 
celiac disease (23). Moreover, the Wnt pathway 
(which is closely related to the beta-catenin func-
tion) can be altered by valproic acid, causing spina 
bifida (24). On the other hand, it has been demon-
strated that a mutation in cysteine protease cal-
pain 3 (CAPN3) can cause muscle dystrophy (25), 
and CAPN3 controls the membrane expression of 
beta-catenin (25).
 Coincidentally, beta-catenin is also altered in 
seminoma. Whereas testicular carcinoma in situ 
and intratubular germ cell neoplasia express beta-
catenin, the latter is absent in seminoma in some 
studies (26). Other groups, nevertheless, found 
expression of beta-catenin in a significant percent-
age of the seminomas studied (27); however, fol-
lowing what is usually found in pilomatricomas, the 
immunoexpression of the protein is seen in cases 
of the gene mutation (21), owing to the abnormal-
ity of beta-catenin degradation (28,29).
 All this might turn in the future, many of the as-
sociations described in the literature between MP 
and other conditions, including the current case, 
from mere coincidences into pathogenically relat-
ed processes.
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